drugset / Trial / NCT00662025
Study Of Sunitinib With Capecitabine In Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate efficacy, safety and pharmacokinetics of sunitinib plus Capecitabine in Japanese patients with advanced/metastatic breast cancer.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-12
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Sunitinib | Small molecule | 37.5 mg | — |